摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,5-dimethyl-2-(1-(methylamino)ethylidene)cyclohexane-1,3-dione | 944-51-4

中文名称
——
中文别名
——
英文名称
5,5-dimethyl-2-(1-(methylamino)ethylidene)cyclohexane-1,3-dione
英文别名
5,5-dimethyl-2-[1-(methylamino)ethylidene]cyclohexane-1,3-dione
5,5-dimethyl-2-(1-(methylamino)ethylidene)cyclohexane-1,3-dione化学式
CAS
944-51-4
化学式
C11H17NO2
mdl
MFCD20542250
分子量
195.261
InChiKey
VQIJFYMAQYBBPX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.14
  • 重原子数:
    14.0
  • 可旋转键数:
    1.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.636
  • 拓扑面积:
    46.17
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES<br/>[FR] PROCÉDÉ DE MODIFICATION DE PEPTIDES IMMOBILISÉS SUR UN SUPPORT SOLIDE PAR DES MOLÉCULES DE LIAISON POUVANT ÊTRE CLIVÉES PAR RÉDUCTION SANS TRACE
    申请人:BELYNTIC GMBH
    公开号:WO2021023892A1
    公开(公告)日:2021-02-11
    The present invention relates to a method for modifying and purifying peptides comprising an immobilizing step, a modification step and a releasing step. In the immobilizing step, a crude linker-tagged peptide L-P is coupled to a solid support yielding an immobilized linker-tagged peptide S-L-P. Subsequently, the immobilized linker-tagged peptide S-L-P is modified with one or more organic molecules yielding an immobilized linker-tagged peptide S-L-mP. Finally, the modified peptide is released via a reduced intermediate RI. The linker molecule is a compound of formula 1, X-Tb-Va-U-Y-Z (1), which can be coupled to a purification resin via the moiety X and to a peptide via the moiety Y under the release of the leaving group Z. T is an optional spacer moiety and V is an optional electron withdrawing moiety. U is an aryl or 5- or 6-membered heteroaryl moiety bound to at least one electron withdrawing moiety V, W or E. The linker is stable under acidic conditions and releases the peptide upon addition of a reducing agent.
    本发明涉及一种修饰和纯化肽的方法,包括固定步骤、修饰步骤和释放步骤。在固定步骤中,将粗链联标记的肽L-P偶联到固体支持上,得到固定的链联标记的肽S-L-P。随后,用一个或多个有机分子修饰固定的链联标记的肽S-L-P,得到固定的链联标记的肽S-L-mP。最后,通过还原中间体RI释放修饰的肽。链联分子是化合物1的化学式,X-Tb-Va-U-Y-Z(1),可以通过基团X偶联到纯化树脂,通过基团Y偶联到肽,释放离去基团Z。T是可选的间隔基团,V是可选的电子吸引基团。U是芳基或与至少一个电子吸引基团V、W或E结合的芳基或5-或6-成员杂芳基基团。该链联在酸性条件下稳定,并在加入还原剂后释放肽。
  • [EN] TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION<br/>[FR] MOLÉCULES DE LIAISON SANS TRACE CLIVABLES PAR RÉDUCTION POUR PURIFICATION DE PEPTIDES
    申请人:BELYNTIC GMBH
    公开号:WO2020043747A1
    公开(公告)日:2020-03-05
    The present invention relates to linker molecules of formula (1), X-Tb-Va-U-Y-Z (1) and a method for purifying peptides using said linker molecules. The linker molecule can be coupled to a purification resin via the moiety X and to a peptide via the moiety Y under the release of the leaving group Z. T is an optional spacer moiety and V is an optional electron withdrawing moiety. U is an aryl or 5- or 6-membered heteroaryl moiety bound to at least one electron withdrawing moiety V, W or E. The linker is stable under acidic conditions and releases the peptide upon addition of a reducing agent.
    本发明涉及公式(1)的连接分子,X-Tb-Va-U-Y-Z(1),以及使用所述连接分子纯化肽的方法。连接分子可以通过基团X与纯化树脂结合,并通过基团Y与肽结合,释放离去基团Z。T是可选的间隔基团,V是可选的电子吸引基团。U是与至少一个电子吸引基团V、W或E相结合的芳基或5-或6-成员杂环芳基。连接在酸性条件下稳定,并在加入还原剂后释放肽。
  • Mikhal'chuk, A. L.; Gulyakevich, O. V., Russian Journal of Organic Chemistry, 1995, vol. 31, # 1.2, p. 138
    作者:Mikhal'chuk, A. L.、Gulyakevich, O. V.
    DOI:——
    日期:——
  • Mikhaltschuk A. L., Guljakewitsch O. W., Zh. organ. khimii, 31 (1995) N 1, S 151
    作者:Mikhaltschuk A. L., Guljakewitsch O. W.
    DOI:——
    日期:——
  • TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES FOR PEPTIDE PURIFICATION
    申请人:BELYNTIC GMBH
    公开号:US20210332082A1
    公开(公告)日:2021-10-28
    The present invention relates to linker molecules of formula (1), X-T b -V a —U—Y—Z (1) and a method for purifying peptides using said linker molecules. The linker molecule can be coupled to a purification resin via the moiety X and to a peptide via the moiety Y under the release of the leaving group Z. T is an optional spacer moiety and V is an optional electron withdrawing moiety. U is an aryl or 5- or 6-membered heteroaryl moiety bound to at least one electron withdrawing moiety V, W or E. The linker is stable under acidic conditions and releases the peptide upon addition of a reducing agent.
查看更多

同类化合物

乙基3-氨基-2-羟基-2,5-二甲基-2H-吡咯-4-羧酸酯 乙基2-氨基-5-甲基-4H-1,3,4-噻二嗪-6-羧酸酯 3-氨基环戊-2-烯-1-酮 3-氨基丁烯酰胺 3-氨基-4,4,4-三氟丁-2-烯酸 3-氨基-2-氰基丙烯酸乙酯 3-氨基-2-氰基-4,4,4-三氟-2-丁烯酰胺 3-氨基-2-氰基-3-碘代-2-烯酸甲酯 3-[甲基(3-甲基丁-2-烯基)氨基]环戊-2-烯-1-酮 3-(甲基氨基)环戊-2-烯-1-酮 3,4-双(1-甲基肼基)-3-环丁烯-1,2-二酮 3,4-二氨基-3-环丁烯-1,2-二酮 2-氰基-3-肼基丙烯酸乙酯 2-氰基-3-二甲基氨基-2-丁酰胺 2-氰基-3-(二甲基氨基)丙烯酸甲酯 2-氨基环庚烯-1-羧酸乙酯 2-氨基环己-1-烯羧酸 2-氨基-1-环戊烯甲酸乙酯 2-氨基-1-环戊烯-1-羧酸 2-氨基-1-环己烯-1-羧酸甲酯 2-氨基-1-环己烯-1-甲酸乙酯 2-[(二甲基氨基)亚甲基]环戊烷-1,3-二酮 2-[(二甲基氨基)亚甲基]-1,3-环己二酮 2-((二甲氨基)亚甲基)环己酮 1-环己基-3-(2-丁氧基羰基-1-环戊烯)脲 1-[(3aR,6aR)-2-氨基-3,3A,4,5,6,6A-六氢-1-戊搭烯基]乙酮 1-(2-氨基-1-环己烯-1-基)乙酮 1,3,6,8-四苯基芘 1,2-二(3,7-二甲基-5-丁氧基-1-氮杂-5-硼杂-4,6-二氧代环辛基)乙烷 (Z)-3-氨基-N-甲氧基-N-甲基-丁-2-烯酰胺 (Z)-3-(丁基氨基甲酰氨基)-2-氰基-丙-2-烯酸 (Z)-3-(丁基氨基甲酰氨基)-2-氰基-丙-2-烯酰胺 (Z)-2-氰基-3-(己基氨基甲酰氨基)丙-2-烯酰胺 (9ci)-2-氨基-1-环戊烯-1-羧酸甲酯 (9CI)-(2-氨基-3,4-二氧代-1-环丁-1-基)-脲 (7CI)-(2-氨基甲酰-2-氰基乙烯基)-脲 (2E)-3-(二甲基氨基)-3-(甲基氨基)丙烯醛 (2E)-3-(二甲基氨基)-3-(甲基氨基)丙烯醛 2-(1-ethoxyaminobutylidene)-5-(2-ethylsulfinylpropyl)-4-methylcyclohexane-1,3-dione 2-(1-ethoxyaminobutylidene)-5-(2-ethylthiopropyl)-4-methylcyclohexane-1,3-dione 2-aminomethylene-malonamic acid ethyl ester 2-[1-dimethylaminomethylidene]-5-methylcyclopentanone 5-di-n-butylamino-endo-tricyclo[5.2.1.02,6]deca-4,8-dien-3-one N'-[(dimethylamino)methylidene]-2-cyano-3-(dimethylamino)-acrylohydrazide 2-{1-[(6-aminohexyl)amino]-3-methylbutylidene}-5,5-dimethylcyclohexane-1,3-dione 3-[(3-bromopropyl)amino]cyclopent-2-enone methyl 2-(1-sec-butylamino)-1-cyclohexen-1-carboxylate (Z)-3-amino-4,4,4-trichlorobut-2-enamide 5-((dimethylamino)methylene)-2,2-dimethylcyclopentanone (+/-)-N-({3-[(dimethylamino)methylidene]-4-oxocyclohexyl}methyl)acetamide